26 results
8-K
EX-1.1
SYRS
Syros Pharmaceuticals Inc.
19 Dec 23
Syros Announces Pricing of $45.0 million Underwritten Offering of Common Stock and Pre-Funded Warrants
4:59pm
and disposal of toxic or other wastes or other hazardous substances and protection of health and safety or the environment which are applicable to its businesses
424B3
SYRS
Syros Pharmaceuticals Inc.
8 Aug 22
Prospectus supplement
5:47pm
government-imposed quarantines, travel restrictions and other public health safety measures, as well as reported adverse impacts on healthcare resources … one time, restricting access to its facilities to those employees who are fully vaccinated, and implementing a number of additional health and safety
S-4
slrq otn9l
18 Jul 22
Registration of securities issued in business combination transactions
7:58am
8-K
EX-1.1
vrex89 sd
20 Jan 21
Syros Announces Proposed Offering of Common Stock
4:04pm
8-K
EX-1.2
up76vpy
8 Apr 19
Entry into a Material Definitive Agreement
12:00am
8-K
EX-1.1
gq5euw395by9chw
8 Apr 19
Entry into a Material Definitive Agreement
12:00am